Form D · Other Health Care
BioMedx Group, Inc.
Baltimore, MD · CIK 0001699297
Offering snapshot reported Mar 10, 2017 · SEC filing
- Reported sold
- $455K Offering amount: $1.11M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100 Reported outside-investor minimum
- First sale
- Feb 22, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 10, 2017 | Initial | $455,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-282269
Source: Form D, filed Mar 10, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rudy Mazzocchi | Director, Executive |
| Juan Carlos Zapata | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1101 E. 33 Rd Street
Baltimore, MD, 21218
Baltimore, MD, 21218